Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001255294-15-000103
Filing Date
2015-02-25
Accepted
2015-02-25 14:56:45
Documents
11
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 MAINBODY mainbody.htm 10-Q/A 465685
2 EXHIBIT 10.26 ex10_26.htm EX-10.26 116207
3 EXHIBIT 31.1 ex31_1.htm EX-31.1 9229
4 EXHIBIT 31.2 ex31_2.htm EX-31.2 9229
5 EXHIBIT 32.1 ex32_1.htm EX-32.1 4142
  Complete submission text file 0001255294-15-000103.txt   4261020

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE rcha-20141231.xml EX-101.INS 449269
7 XBRL SCHEMA FILE rcha-20141231.xsd EX-101.SCH 47961
8 XBRL CALCULATION FILE rcha-20141231_cal.xml EX-101.CAL 36650
9 XBRL DEFINITION FILE rcha-20141231_def.xml EX-101.DEF 131141
10 XBRL LABEL FILE rcha-20141231_lab.xml EX-101.LAB 224961
11 XBRL PRESENTATION FILE rcha-20141231_pre.xml EX-101.PRE 217213
Mailing Address 9595 WILSHIRE BLVD., SUITE 900 BEVERLY HILLS CA 90212
Business Address 9595 WILSHIRE BLVD., SUITE 900 BEVERLY HILLS CA 90212 (424) 230-7001
Rich Pharmaceuticals, Inc. (Filer) CIK: 0001504389 (see all company filings)

EIN.: 463259117 | Fiscal Year End: 0331
Type: 10-Q/A | Act: 34 | File No.: 000-54767 | Film No.: 15647249
SIC: 2834 Pharmaceutical Preparations